European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document
about
Cancer prevention: state of the art and future prospectsHuman papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspectiveValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelWilfully out of sight? A literature review on the effectiveness of cancer-related decision aids and implementation strategiesHigh-risk human papillomavirus targets crossroads in immune signalingEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancersRisk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort studyVaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trialEuropean guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).Intent to participate in future cervical cancer screenings is lower when satisfaction with the decision to be vaccinated is neutral.Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.The influence of total hysterectomy in a cervical cancer screening population: a register-based cross-sectional studyHigh-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPVHPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsyRationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)Fractal analysis of cervical intraepithelial neoplasiaAccuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis.Annual Papanicolaou screening for 5 years among human papillomavirus-negative womenhr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopyAge-specific occurrence of HPV16- and HPV18-related cervical cancer.Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.Measuring the nature and duration of symptoms of cervical cancer in young women: developing an interview-based approach.Teenage cervical screening in a high risk American populationIntegrated cervical smear screening using liquid based cytology and bioimpedance analysis5-aminolevulinic-acid-based fluorescence spectroscopy and conventional colposcopy for in vivo detection of cervical pre-malignancyEnhancing participation to health screening campaigns by group interactionsThe end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.Screening of cervical cancer in Catalonia 2006-2012.Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 yearsThe Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.Optimizing technology for cervical cancer screening in high-resource settings.Triage of HPV positive women in cervical cancer screening.Priority Setting for Improvement of Cervical Cancer Prevention in IranTriage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancerRisk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE studyA comparison between Pap and HPV screening tests and screening methods.
P2860
Q26770668-9B58B950-D73F-43AA-9EAF-797BFFC60FBAQ26799791-97885172-051F-4B77-8F41-83B8AC085116Q27001399-06DD348C-5ED3-4D02-B862-48A0C022EFB6Q28071768-6F6ADD11-B120-43A4-93F7-957B54895985Q28084802-575FA21A-B6EB-44A8-9138-8C52DE9A3AA8Q28282973-698C043C-6096-4C50-8A64-FB6AFE26C088Q28603529-50D0E0AE-8116-42E4-8481-803F2F1D6295Q28650225-6B4D662B-15DC-4191-B4F0-32ACEB84B0B8Q30485842-2C4DF319-2725-421A-B679-3DB111265139Q30791109-9310FC1A-4546-428A-9E50-D7BBA8893EA0Q33734307-78F16E7F-E28F-4ACB-94FF-9D09B79A08B0Q33743234-08915C41-149B-48AE-AE7A-D7D68AAF12B1Q33816398-A302E269-77CA-48FF-82F5-1E324897B99CQ33890037-FD3C6898-D3C4-48C6-BF7F-A118ABB6A431Q33963857-CD26AE84-BBCD-4F17-8BAA-063F65B155FBQ34048160-4AD3ACEA-1640-44C1-91D5-0A4AD3BC745EQ34286142-5A04CE80-7497-4374-A3E5-FD899799E319Q34323163-1ECA53C0-3EE3-4C4C-8BD4-16579F06BEDEQ34375539-352A3607-4CDA-4232-B350-5607590B392DQ34929075-7A1DDFAA-A20B-4127-B897-D61F33A5E245Q34979227-AC73FF9F-A443-4E0F-AEC6-1F671AA0AC87Q35013844-4A5A2AFB-58A1-43CE-A791-C4363C70F83AQ35036033-B9213A3A-9A15-49BF-93A5-FC6EEFE62D78Q35039230-DB7D8302-CB3E-4CC7-B193-7645E90A6DB8Q35057935-3A9F6C27-AB17-4CB5-B792-DC041759EA6BQ35145551-6974B710-EAA6-435D-BBF4-6D31ACAF2EABQ35518765-5A4E1ECA-4F6B-43D7-8EDC-F9FFE1E6601EQ35531836-E5748A56-051B-46E1-BD66-86648D53FAEAQ35534341-901AE6F6-615C-492A-923E-3F4718446658Q35563325-2427128E-B47A-46F1-A6DF-7F421E4EA524Q35605626-4781E0A5-3EDE-4808-B64E-E29167FA4CFCQ35641828-DB9A30B2-9907-42A9-A553-03EC6685ED28Q35821324-604BF7B2-5438-4D56-BBD8-2F3FBAFA7619Q36045104-1AFBE652-833C-4441-9E7B-38F23EA4EB4FQ36319941-A69820C1-10ED-43F5-A888-F889E9174A5CQ36679896-13CCCBC7-36F0-44CB-9AAD-6BB55D650F49Q36760082-75FE864A-2E87-48AB-A10E-850201C8D060Q36803663-DCB11E86-9545-41DB-9276-D98B364BFF61Q36977595-79C9BABE-D62A-40E4-8B23-2A936476204EQ37107997-1BE5EFA7-8ACF-4F8C-BC05-4366A5B0FE93
P2860
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
European Guidelines for Qualit ...... cond edition--summary document
@ast
European Guidelines for Qualit ...... cond edition--summary document
@en
European Guidelines for Qualit ...... cond edition--summary document
@nl
type
label
European Guidelines for Qualit ...... cond edition--summary document
@ast
European Guidelines for Qualit ...... cond edition--summary document
@en
European Guidelines for Qualit ...... cond edition--summary document
@nl
prefLabel
European Guidelines for Qualit ...... cond edition--summary document
@ast
European Guidelines for Qualit ...... cond edition--summary document
@en
European Guidelines for Qualit ...... cond edition--summary document
@nl
P2093
P2860
P3181
P356
P1433
P1476
European Guidelines for Qualit ...... cond edition--summary document
@en
P2093
L von Karsa
P2860
P304
P3181
P356
10.1093/ANNONC/MDP471
P407
P50
P577
2010-03-01T00:00:00Z